期刊
JOURNAL OF PERSONALIZED MEDICINE
卷 11, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/jpm11030238
关键词
gut microbiota; type 2 diabetes; non-alcoholic fatty liver disease; fibroscan
资金
- Kaohsiung Municipal Ta-Tung Hospital [KMTTH-108-015]
This study found a positive correlation between the abundance of Firmicutes phylum and the severity of NAFLD in T2D patients. The gut microbiota, specifically Firmicutes, could potentially serve as a predictor for NAFLD severity in T2D patients.
Introduction: Non-alcoholic fatty liver disease (NAFLD) remains an important health issue worldwide. The increasing prevalence of NAFLD is linked to type 2 diabetes (T2D). The gut microbiota is associated with the development of NAFLD and T2D. However, the relationship between gut microbiota and NAFLD severity has remained unclear in T2D patients. The aim of this study was to evaluate the relationship of gut microbiota with the severity of NAFLD in T2D patients. Methods: This cross-sectional study used transient elastography (FibroScan) to evaluate the severity of hepatic steatosis. We utilized qPCR to measure the abundance of Bacteroidetes, Firmicutes, Faecalibacterium prausnitzii, Clostridium leptum group, Bacteroides, Bifidobacterium, Akkermansia muciniphila, and Escherichia coli. Results: Of 163 T2D patients, 83 with moderate to severe NAFLD had higher abundance of bacteria of the phylum Firmicutes with respect to 80 patients without NAFLD or with mild NAFLD. High abundance of the phylum Firmicutes increased the severity of NAFLD in T2D patients. A positive correlation between NAFLD severity and the phylum Firmicutes was found in T2D male patients with body mass index >= 24 kg/m(2) and glycated hemoglobin Firmicutes is significantly and positively associated with NAFLD severity in T2D patients. The gut microbiota is a potential predictor of NAFLD severity in T2D patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据